Lamdong Pharmaceutical Joint Stock Company reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was VND 45,325.27 million compared to VND 49,045.76 million a year ago. Net loss was VND 9,864.65 million compared to VND 11,561.51 million a year ago.

Basic loss per share from continuing operations was VND 777 compared to VND 910 a year ago. Diluted loss per share from continuing operations was VND 777 compared to VND 910 a year ago.